US Corporate Board Director Changes SEC Filings — April 03, 2026

03-04-2026

Health Catalyst, Inc. entered into a Transition Agreement with former CEO Daniel Burton on March 31, 2026, following his accelerated retirement from the CEO position on February 12, 2026, as previously reported in a Form 8-K on February 18, 2026. Under the agreement, Burton will serve as a strategic advisor until December 31, 2026, receiving an average monthly base salary of $10,000 starting March 1, 2026, in exchange for forfeiting all unvested restricted stock units eligible for vesting after March 2, 2026, and providing a general release of claims. This arrangement facilitates a smooth transition of his prior responsibilities.

• ·Transition Agreement dated March 31, 2026, attached as Exhibit 10.1
• ·Previous Form 8-K filed February 18, 2026, regarding Burton's retirement notice on February 12, 2026
• ·Strategic advisor role ends December 31, 2026

03-04-2026

Atlantic International Corp. received default notices from SPP Credit Advisors on March 30, 2026, under the April 2025 Financing Agreement and June 2024 Bridge Loan, alleging covenant breaches, prompting SPP to reserve rights to accelerate obligations, exercise pledges over Lyneer subsidiaries, and replace management. The company disputes the defaults, claiming the debt (less than $50M) was satisfied via SPP's sale of over $77M in shares, and filed a lawsuit on April 1, 2026, seeking an injunction against SPP's actions. COO Mathew Evelt resigned the same day but was terminated for cause after allegedly joining SPP.

• ·SPP default notices dated March 30, 2026, did not demand repayment or include payoff amounts.
• ·Company is an emerging growth company trading as ATLN on Nasdaq Global Market.
• ·Lawsuit filed April 1, 2026, in Supreme Court of New York, County of New York.

03-04-2026

Village Farms International, Inc. (VFF) announced a succession plan for Chief Financial Officer Stephen Ruffini, who will transition after 17 years of service to a new role leading M&A activities, remaining as CFO until a permanent replacement is identified. The company highlighted its strong financial position and growth strategy combining organic investments with accretive acquisitions. CEO Michael DeGiglio commended Ruffini's contributions, including NASDAQ uplisting and cannabis expansion.

• ·Hired as CFO in 2009; instrumental in NASDAQ uplisting, debt/equity financings, and cannabis expansion.
• ·Operates EU-GMP certified cannabis facility in Delta, British Columbia, exporting to international medical markets.
• ·Clean Energy division transforms landfill gas into renewable natural gas.

03-04-2026

On April 2, 2026, the Board of Forum Markets, Incorporated (formerly ETHZilla Corp) approved equity awards under the 2025 Omnibus Incentive Plan to CEO and Chairman McAndrew Rudisill and CFO John Saunders to aid retention and align interests with shareholders. Rudisill received a one-time initial award with a grant date value of $4,285,500 (two times the anticipated annual award of $2,142,750) and a pro-rated 2025 award of $898,194, while Saunders received an award valued at $750,000. Each award comprises 60% performance stock units (PSUs) vesting on share price hurdles of $5.00, $7.50, and $10.00, and 40% restricted stock units (RSUs) vesting over three years from August 1, 2025.

• ·A prior grant of 136,500 shares of restricted common stock to McAndrew Rudisill on November 12, 2025, was rescinded by the Board on December 1, 2025, with his approval.
• ·PSUs vest in one-third tranches upon share price hurdles of $5.00 (min 1-year service), $7.50 (min 2-year), $10.00 (min 3-year), achieved if closing price met for 30 trading days in any 60-day period within 5 years; unachieved PSUs forfeit.
• ·RSUs vest in one-third installments on the first, second, and third anniversaries of August 1, 2025, subject to continued employment.
• ·Awards include accelerated vesting provisions on termination without Cause pre-Change in Control or post-Change in Control termination without Cause or for Good Reason.

03-04-2026

Ensysce Biosciences, Inc. announced the resignation of Curtis Rosebraugh from its Board of Directors, effective April 1, 2026; he had served on the Nominating and Corporate Governance Committee. The resignation notice is attached as Exhibit 17. No additional details on reasons or successor were provided in the filing.

• ·Resignation notice dated and effective April 1, 2026; Form 8-K filed April 3, 2026
• ·Common Stock trades as ENSC on Nasdaq

03-04-2026

On March 30, 2026, Fidelity National Information Services, Inc. (FIS) was notified that Board Director Mark Benjamin will not stand for re-election at the 2026 annual meeting of shareholders, a decision not due to any disagreement with the Company's operations, policies, or practices. In connection with his departure, the Board approved reducing its size from ten to nine directors, effective immediately following the 2026 Shareholder Meeting. FIS's CEO Stephanie Ferris thanked Mr. Benjamin for his extraordinary contributions and dedication.

• ·Mr. Benjamin’s decision was not due to any disagreement with the Company on any matters relating to the Company’s operations, policies, or practices.

03-04-2026

On March 31, 2026, Ms. Betsy Atkins resigned from the Board of Directors of Rackspace Technology, Inc. The resignation did not result from any dispute or disagreement with the Company or the Board on any matter relating to the Company's operations, policies, or practices. The 8-K filing was submitted on April 3, 2026.

03-04-2026

Ian T. Clark resigned from GoodRx Holdings, Inc.'s Board of Directors, including the Nominating & Governance Committee, effective March 31, 2026, with no disagreement on operations, policies, or practices. To achieve balanced membership across director classes post-resignation, the Board moved Wendy Barnes (CEO, President, and Director) from Class I (term expiring 2027) to Class III (term expiring 2026) via resignation and re-election on April 1-2, 2026, maintaining her uninterrupted service. The Board now consists of three directors in each of Classes I, II, and III.

• ·Filing signed on April 3, 2026

03-04-2026

Safe Pro Group Inc. appointed Jarret Mathews as Chief Operating Officer effective April 1, 2026, with an annual base salary of $200,000, a $50,000 commencement bonus, $1,000 monthly home-office allowance, and eligibility for up to 100% bonus plus equity grants including 20,000 inducement shares and performance options tied to revenue milestones. The company also amended CFO Theresa Carlise's employment agreement effective the same date, increasing her base salary to $225,000, adding a $1,000 monthly automobile allowance, and providing full health insurance coverage or a $2,000 monthly medical allowance. No performance declines or financial metrics were reported.

• ·Jarret Mathews' employment term is initially two years, auto-renewing annually with 30 days' notice of non-renewal.
• ·Mr. Mathews, age 50, previously led Phase Zero Consulting since July 2024 and served in the US Army as Director, Joint Acquisition Task Force from July 2021 to July 2024.
• ·No family relationships or arrangements influencing Mr. Mathews' selection; no material related transactions under Item 404(a).
• ·Exhibits 10.1 (Mathews Employment Agreement) and 10.2 (Carlise Amendment) filed with the 8-K.

03-04-2026

On April 3, 2026, the Compensation Committee of Oil-Dri Corporation of America approved the Second Amendment to the 2005 Deferred Compensation Plan, which updates the definition of Eligible Employee or Director to align with current salary grades, clarifies Separation from Service, and changes Earnings crediting to at least quarterly. The Committee also approved amended forms of restricted stock agreements for Class A Common Stock, Common Stock, Class B Stock (employees), and Common Stock (directors) under the 2006 Long-Term Incentive Plan to better align with current practices. No financial impacts or performance metrics were disclosed.

03-04-2026

On March 31, 2026, MercadoLibre's Board established performance goals under the 2026 Bonus Program for five NEOs, tying bonuses to metrics including net revenues, financial income, operating income, adjusted total payment volume, and Competitive Net Promoter Score, with target bonuses at 33.33% of annual base salary adjustable by +/-50% based on individual performance. The Board also adopted the 2026 Long Term Retention Program, setting target awards totaling $41,500,000 for the NEOs payable annually over six years (first payment January-April 2027), comprising fixed payments and stock price-linked components. No declines or flat metrics reported in performance goals.

• ·Bonus metrics in constant dollars: Net revenues and financial income, Income from operations, Total payment volume-adjusted (excluding P2P), Competitive Net Promoter Score.
• ·LTRP Grant Date: January 1, 2026; payments subject to continued employment; stock price based on average closing price over final 60 trading days of prior year.
• ·Exhibit 10.1: Full 2026 LTRP document filed.

03-04-2026

At the NeuroOne Medical Technologies Corporation annual stockholder meeting on April 3, 2026, with 30,272,834 shares present representing 59.72% quorum, shareholders elected Jeffrey Mathiesen and Edward Andrle as Class III directors for three-year terms, ratified Baker Tilly US, LLP as independent auditors for FY ending September 30, 2026, approved a reverse stock split amendment at a 1-for-2 to 1-for-15 ratio at Board discretion, and approved the First Amendment to the 2025 Equity Incentive Plan increasing the share reserve by 1,500,000 new shares to 4,500,000 plus a 5% annual evergreen increase for five years starting 2027. All proposals passed with majority votes, however Proposal 4 (equity plan) received 3,415,319 votes against and 11,393,265 broker non-votes, while director elections saw some withheld votes (494,745 for Mathiesen, 705,164 for Andrle). Proposal 5 authorizing adjournments also passed overwhelmingly.

• ·Proposal 2 (auditor ratification): 30,031,054 For; 70,706 Against; 171,074 Abstain.
• ·Proposal 3 (reverse stock split): 28,408,499 For; 1,780,031 Against; 84,304 Abstain.
• ·Proposal 4 (equity plan): 15,146,194 For; 3,415,319 Against; 318,056 Abstain; 11,393,265 Broker Non-Votes.
• ·Proposal 1 (directors): Jeffrey Mathiesen - 18,384,823 For; Edward Andrle - 18,174,404 For.
• ·Proposal 5 (adjournment): 29,020,938 For; 1,067,842 Against; 184,052 Abstain.
• ·Equity plan evergreen: automatic annual increase of 5% of Fully Diluted Shares on Jan 1 from 2027-2031, subject to Board reduction.

03-04-2026

On April 2, 2026, Gibraltar Industries, Inc.'s Compensation and Human Capital Committee approved special discretionary cash bonuses totaling $528,584 to four named executive officers, equal to 75% of their 2025 target bonuses under the MICP (in addition to the 25% already earned), recognizing efforts on multiple acquisitions, Renewables business divestiture preparation, and OmniMax integration. The bonuses are contingent on one-year continued employment in good standing, with repayment required if an officer resigns or is terminated for cause before the anniversary. No performance declines or flat metrics were noted in the context of these awards.

• ·Special Bonuses approved for year ended December 31, 2025 performance.
• ·Repayment required within 30 days if officer resigns or is terminated for cause before one-year anniversary of approval.
• ·Company may deduct unpaid bonus amounts from amounts owed to officer upon separation.

03-04-2026

On April 1, 2026, ClearOne, Inc. entered into a letter agreement with Derek L. Graham for his continued service as CEO on a transitional consulting basis after his prior employment agreement expired on March 31, 2026. Under the agreement, Mr. Graham will provide up to 10 hours per week of consulting services at $160 per hour while performing all CEO functions, with no fixed term and terminable by either party at any time. The full letter agreement is filed as Exhibit 10.1.

• ·Letter agreement filed as Exhibit 10.1
• ·Event reported date: April 3, 2026 (earliest event: April 1, 2026)

03-04-2026

On March 31, 2026, Skye Bioscience, Inc. repriced all outstanding stock options for current full-time employees and executives, covering 2,420,978 shares, to a new exercise price of $0.6150 per share from prior ranges of $1.055 to $14.56, aiming to retain and motivate personnel without dilution or additional cash costs. The Board also appointed John P. Sharp as Chief Financial Officer effective immediately via a Master Services Agreement with Lohman & Associates, billing at a flat rate of $25,600 for up to 64 hours per month. Punit Dhillon (CEO) holds 1,103,959 repriced options and Tuan Diep (COO) holds 396,295 repriced options.

• ·Repriced options granted prior to December 31, 2025 under the 2014 Omnibus Plan or 2024 Inducement Plan.
• ·John P. Sharp's prior roles: CFO at SaNOtize (Dec 2022-Oct 2025), PhaseBio (Apr 2016-Nov 2022), HUYA (Mar 2014-Dec 2015), Ligand (Apr 2007-Mar 2014); former auditor at PricewaterhouseCoopers LLP.
• ·No family relationships or related party transactions for Mr. Sharp under Items 401(d) or 404 of Regulation S-K.

03-04-2026

David Chang resigned from the Board of Directors of Battalion Oil Corporation, including his role as Chairman of the Compensation Committee, effective March 31, 2026, and stated he will not stand for re-election. The resignation is explicitly not due to any disagreement with the Company on matters related to operations, policies, or practices.

• ·Resignation letter dated March 30, 2026
• ·Company address: 820 Gessner Road Suite 1100, Houston, Texas 77024

03-04-2026

On April 2, 2026, Tai A. Thornock, Chief Accounting Officer and principal accounting officer of Finance of America Companies Inc., notified the company of his retirement effective May 15, 2026; the departure was not due to any disagreement with management or the Board. Following his retirement, Matthew A. Engel, the Chief Financial Officer, will serve as the principal accounting officer in addition to his existing role as principal financial officer. Mr. Thornock may remain as a consultant for a transitional period, and the company expressed gratitude for his contributions.

• ·Filing date: April 3, 2026
• ·Company address: 5830 Granite Parkway, Suite 400, Plano, Texas 75024
• ·Class A Common Stock trading symbol: FOA on New York Stock Exchange

03-04-2026

Getty Images Holdings, Inc. appointed Jeffrey Titterton, a Board member since October 18, 2022, to its Audit Committee on April 3, 2026, determining he meets independence requirements under Rule 10A-3 and NYSE standards. James Quella resigned from the Board and Audit Committee effective April 1, 2026, with no disagreements on company operations, policies, or practices. The Board size remains at eleven directors, with the vacancy to be filled later.

• ·Jeffrey Titterton appointed to Board on October 18, 2022.
• ·James Quella resignation submitted March 31, 2026.
• ·Earliest event reported: March 29, 2026.

03-04-2026

Mastech Digital, Inc. and CEO Nirav Patel agreed to pay his 2025 annual performance bonus of $616,932 in the form of 100,314 restricted shares, converted at a 30-day VWAP of $6.15, instead of cash. The shares vest immediately but are subject to a disposal prohibition until March 30, 2028, with restrictions lapsing upon separation, death, or disability. This is documented in a Restricted Stock Agreement dated March 30, 2026.

• ·Restricted shares subject to immediate vesting.
• ·Disposal prohibition until March 30, 2028, lapsing on separation from Company, death, or disability.
• ·Governed by Executive Employment Agreement dated November 1, 2024.

03-04-2026

On April 1, 2026, Mark Hilz, Chief Operating Officer, Corporate Secretary, and Board member of HeartSciences Inc., passed away at age 67 after a period of illness; he had served on the Board since 2013 and in his executive roles since March 2022. The company does not anticipate hiring a replacement COO or any disruptions to operations, as the MyoVista Insights™ platform has launched and the MyoVista® wavECG™ device was submitted for FDA 510(k) clearance in December 2025.

• ·Mr. Hilz was 67 years old at the time of his passing.
• ·MyoVista® wavECG™ submitted to FDA for 510(k) premarket clearance in December 2025.

03-04-2026

On March 31, 2026, J. Mark Hemmann resigned from ESG Inc.'s Board of Directors and all committees, effective immediately, stating it was not due to any disagreement with the company's operations, policies, or practices. On April 1, 2026, the Board appointed Joseph F. Rossetti, age 43 with over 15 years in financial services, to fill the vacancy; he was also appointed to the Audit, Compensation, and Nominating and Corporate Governance Committees as Chair of Audit and Compensation. Mr. Rossetti qualifies as an independent director under OTCQB standards and is financially sophisticated for the Audit Committee, with no prior arrangements, family relationships, or disclosable transactions.

• ·Mr. Rossetti's experience includes institutional capital markets, investment banking advisory, retail finance, IPOs, SPAC transactions, private placements, and bridge financings.
• ·No compensatory arrangement entered into with Mr. Rossetti at this time; future arrangements to be disclosed if applicable.
• ·Filing includes Exhibit 17.1: Resignation Letter of J. Mark Hemmann.

03-04-2026

On March 30, 2026, Daniel Schurr resigned from the CHS Inc. Board of Directors, effective immediately, to accept a seat on the board of Nationwide Mutual Insurance Company. Schurr had served as a director since 2006, including as Chair from 2017 to December 2025, representing Region 7 (Alabama, Arkansas, Florida, Georgia, Iowa, Louisiana, Mississippi, Missouri, North Carolina, South Carolina, and Tennessee). A replacement Region 7 director will be elected by CHS members at the 2026 Annual Meeting.

• ·Region 7 includes: Alabama, Arkansas, Florida, Georgia, Iowa, Louisiana, Mississippi, Missouri, North Carolina, South Carolina, Tennessee

03-04-2026

On March 31, 2026, the Board of Directors of Global-Smart.Tech Inc. appointed Leonel Agustin Peleriti as an Independent Director, effective immediately. Mr. Peleriti, a former Technology Solutions Analyst at Mercado Libre (2020-2023) with a Bachelor’s degree in Information Systems Engineering from the National University of Córdoba, was confirmed to meet OTC Markets independence standards with no material conflicts, family relationships, or transactions exceeding $120,000. The Company is an emerging growth company with principal offices in Tivat, Montenegro.

• ·Company incorporated in Wyoming (IRS EIN: 98-1664763; Commission File Number: 000-56781)
• ·Principal executive offices: Yehor Rodin Kava b.b., 85320, Tivat, Montenegro; Phone: +1-205-2165924
• ·No securities registered pursuant to Section 12(b) of the Act
• ·No family relationships between Mr. Peleriti and any directors or executive officers
• ·No material plan, contract, or arrangement involving the new director in connection with the appointment

03-04-2026

At Hewlett Packard Enterprise Company's 2026 Annual Meeting on April 1, 2026, stockholders elected all 12 director nominees with strong majorities (ranging from ~95% to ~99% votes for), ratified Ernst & Young LLP as auditors with 98% support, and approved Amendment No. 5 to the 2021 Stock Incentive Plan increasing shares reserved by 22 million. However, the advisory vote on executive compensation passed with only 74% support amid 264 million votes against, and a stockholder proposal on discrimination reporting failed overwhelmingly with just 1% support.

• ·Broker non-votes: 157,291,562 across director elections, Proposals 3, 4, and 5
• ·Proposal 2 (auditor ratification): 1,143,409,866 votes for, 18,711,455 against
• ·Patricia F. Russo received the highest against votes among directors (47,841,595)

03-04-2026

LSB Industries, Inc. (LXU) filed an 8-K on April 3, 2026, under Items 5.02, 5.03, and 7.01, attaching EX-99.1 as its Third Amended and Restated Bylaws, effective as amended through April 2, 2026. The bylaws outline standard governance provisions including principal office in Oklahoma City, Oklahoma; stockholder meeting procedures, quorum (majority of voting stock), voting (one vote per share), notice requirements (10-60 days), special meetings, and detailed processes for actions by written consent without a meeting. No financial metrics, performance changes, or operational impacts are disclosed.

• ·Principal office: Oklahoma City, County of Oklahoma, State of Oklahoma
• ·Quorum for stockholder meetings: holders of record of a majority of the stock issued and outstanding, entitled to vote
• ·Notice of meetings: not less than 10 nor more than 60 days before the date
• ·Written consent record date: 10th day following request or determination
• ·Written consents valid for maximum of 60 days after record date

03-04-2026

Indaptus Therapeutics, Inc. announced the resignation of Chief Financial Officer Nir Sassi on April 1, 2026, which was not due to any disagreement with the company's operations, policies, or practices. The Board appointed Qinglai Lu as an independent director effective April 8, 2026, and Yu Ding as the new Chief Financial Officer effective April 1, 2026. Additionally, Matthew McMurdo resigned from the Audit Committee, with Qinglai Lu and Jerome Jabbour appointed in his place.

• ·Qinglai Lu: Over 20 years experience in corporate finance, banking; Managing Partner at Plunkett Capital since May 2019; Former Head of Financing Solutions, Private Banking Asia at Goldman Sachs (2018-2019); CFA charterholder since 2005.
• ·Yu Ding: Former Vice President and CFO of Grand Auto Service Group Co., Ltd. (Aug 2023-Jan 2026) and Grand Baoxin Auto Group Limited; VP of China ZhengTong Auto Services Holdings Limited (May-Dec 2019); MBA from University of Canberra (2006).
• ·Event date: March 31, 2026; Filing date: April 3, 2026.

03-04-2026

On March 30, 2026, Intel Corporation announced that April Miller Boise, its Executive Vice President and Chief Legal Officer, will separate from the company effective June 1, 2026. Ms. Miller Boise will receive severance benefits under the Intel Corporation Executive Severance Plan in exchange for a release of claims. The Form 8-K was filed on April 3, 2026, and signed by David Zinsner, Executive Vice President and Chief Financial Officer.

• ·Date of earliest event reported: March 30, 2026
• ·Items reported: 5.02 (Departure of Directors or Certain Officers) and 9.01 (Financial Statements and Exhibits)

03-04-2026

On March 31, 2026, Patrick O’Connell's resignation as Chief Financial Officer of AMC Networks Inc. became effective, as previously announced on January 22, 2026, and was not due to any disagreement with the company's operations, policies, or practices. Michael J. Sherin III, the company's Chief Accounting Officer, assumed the responsibilities of principal financial officer on an interim basis effective the same date.

• ·Resignation previously announced on January 22, 2026
• ·Filing signed by Anne G. Kelly on April 3, 2026

03-04-2026

WW International announced significant leadership changes, including the departure of Tara Comonte effective March 31, 2026, the establishment of an Office of the CEO comprising CFO Felicia DellaFortuna and COO Jon Volkmann, and the formation of a Transition Committee (Gene Davis, Carney Hawks, Mike Mason, Nikolaj Sjoqvist) to oversee operations and conduct a CEO search. Separately, Debra Cotter was appointed Chief Legal Officer effective April 10, 2026, replacing departing Jacqueline Cooke, while directors Julie Bornstein and Fallon O’Connor resigned without any disagreements. The Board expressed confidence in the strategy and long-term prospects, reaffirming Q1 2026 subscriber estimates and FY 2026 financial guidance previously provided.

• ·Tara Comonte’s departure coincided with the expiration of her employment agreement.
• ·Board resignations of Julie Bornstein and Fallon O’Connor not due to any disagreements on operations, policies, or practices.
• ·Investor inquiries: John Mills or Anna Kate Heller (WeightWatchers@icrinc.com); Media: Lizzy Levitan (WW@hunt-gather.com)

03-04-2026

NewtekOne, Inc. renewed one-year employment agreements effective April 1, 2026, with executives Barry Sloane (CEO and President), Michael A. Schwartz (Chief Legal Officer and Corporate Secretary), and Frank DeMaria (Chief Financial Officer and Executive Vice President), with terms unchanged except for added non-renewal payments equal to one year of base compensation in some agreements. The Company's subsidiary, Newtek Bank, N.A., similarly renewed the employment agreement with President Peter Downs on identical terms. These renewals ensure executive continuity with no reported changes to compensation structures beyond the non-renewal provision.

• ·Renewals filed under Item 5.02 of Form 8-K on April 3, 2026.
• ·Employment agreements to be filed as exhibits in next Quarterly Report on Form 10-Q.
• ·Change in Control Agreements remain unchanged from Form 10-K for year ended December 31, 2024.

03-04-2026

Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) announced changes to its Board of Directors, with the appointment of Kim Popovits as a new Director and the departure of Ed Mathers, who served since 2013. CEO David Meeker praised Popovits' 40+ years of experience in biotechnology commercialization from Genomic Health and Genentech, stating her expertise will support the company's growth mission. No other operational or financial impacts were disclosed.

• ·Ed Mathers served on the Board since 2013.
• ·Rhythm’s headquarters is in Boston, MA.
• ·Setmelanotide (IMCIVREE) is approved by FDA, EC, and MHRA for specific rare neuroendocrine diseases including BBS, POMC, PCSK1, LEPR deficiencies, and acquired hypothalamic obesity.

03-04-2026

On March 30, 2026, Mr. Yushi Guo and Mr. Jerry Qin resigned from the Board of Directors of Allied Gaming & Entertainment Inc. and all committees thereof, effective immediately. The Board reconstituted its committees as follows: Audit Committee (Mao Sun, Jingsheng Lu, Yuanfei Qu); Compensation Committee (Yuanfei Qu, Chi Zhao, Mao Sun); Nominating and Corporate Governance Committee (Chi Zhao, Jingsheng Lu, Mao Sun). No reasons for the resignations were provided.

• ·Form 8-K filed on April 03, 2026, reporting event dated March 30, 2026.
• ·Company's common stock: par value $0.0001 per share, traded as AGAE on NASDAQ.

03-04-2026

Climb Bio, Inc. announced on April 1, 2026, the mutual separation of Cindy Driscoll, its Senior Vice President, Finance and principal accounting officer, effective April 30, 2026. Dr. Susan Altschuller, the Company's Chief Financial Officer since October 2025, will also serve as principal accounting officer effective the same date, with no changes to her compensatory arrangements. The change maintains continuity in financial leadership, as Dr. Altschuller has prior CFO experience at Dragonfly Therapeutics, Cerevel Therapeutics (acquired by AbbVie), and ImmunoGen.

• ·Dr. Altschuller, age 44, holds a BSE in Biomedical Engineering from Tulane University, a Ph.D. in biomedical engineering from the Illinois Institute of Technology, and an MBA from MIT Sloan.
• ·Dr. Altschuller has no family relationship with any Company officers or directors and no disclosable interests under Item 404(a) of Regulation S-K.
• ·The Form 8-K was filed on April 3, 2026.

03-04-2026

Alessandro Perucchetti, formerly Executive Vice President and President, Whirlpool North America, terminated employment effective March 31, 2026, as part of the company's talent planning process, receiving a $2,997,560 severance payment in two installments. He remains eligible for a prorated 2026 annual incentive award based on company performance. The agreement requires compliance with waiver/release of claims, two-year restrictive covenants, and ongoing cooperation.

• ·First installment payable within 30 days of March 31, 2026 termination date; second installment in March 2027.
• ·Prorated incentive under 2026 Executive Performance Excellence Plan determined by Human Resources Committee in February 2027.
• ·Prior notice of departure reported in November 5, 2025 Form 8-K, effective January 1, 2026 from executive officer role.

03-04-2026

On March 30, 2026, Jeff Haywood resigned from the Board of Directors and the Human Capital Management and Compensation Committee of Definitive Healthcare Corp., effective immediately, with no disagreements regarding the company's operations, policies, or practices. In connection with the resignation, the Board size was reduced from 9 to 8 members, and the Compensation Committee size from 3 to 2 members.

03-04-2026

Torrid Holdings Inc. appointed Ashlee Wheeler, age 41, as Chief Commercial Officer effective April 1, 2026. Ms. Wheeler, who has been with the company for approximately 15 years including as Chief Planning and Strategy Officer since June 2024, previously spent five years at Lucky Brand Jeans. In her new role, she will receive an initial annual base salary of $625,000 and be eligible for an annual cash bonus with a target of 75% of base salary, prorated for fiscal 2026.

• ·Ms. Wheeler promoted from Chief Planning and Strategy Officer role held since June 2024
• ·No family relationships with directors or executives; no related-party transactions under Item 404(a)
• ·Equity grants to be determined by the Board of Directors

03-04-2026

Keel Infrastructure Corp. (formerly Bitfarms Ltd., ticker BITF) filed an 8-K on April 3, 2026, disclosing under Item 5.02 the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, with the event dated April 1, 2026. Item 9.01 includes financial statements and exhibits. No specific names, details on changes, or financial metrics are detailed in the provided filing content.

• ·CIK: 0001812477
• ·SEC File Number: 001-40370
• ·State of Incorporation: DE
• ·Fiscal Year End: 12/31
• ·Business Address: 120 Broadway, Suite 1075, New York, NY 10004
• ·Date of Name Change from Bitfarms Ltd.: May 18, 2020

03-04-2026

On March 30, 2026, Jeff Park resigned as Chief Investment Officer of ProCap Financial, Inc., effective April 3, 2026, from all positions with the Company and its subsidiaries; the resignation was voluntary with no disagreements on operations, policies, or practices. The Company entered into a Separation Agreement providing continued base salary through May 8, 2026, vesting of restricted stock units under the 2025 Equity Incentive Plan through August 2026, and group health insurance for up to six months post-effective date. No successor Chief Investment Officer has been appointed.

• ·Separation Agreement waives Mr. Park's non-competition covenant but maintains confidentiality, non-solicitation, and non-disparagement obligations.
• ·Full text of Separation Agreement filed as Exhibit 10.1.